Revenues of Hoth Therapeutics, Inc. for 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Hoth Therapeutics, Inc. quarterly Revenues in USD history and change rate for 31 Mar 2024.
  • Hoth Therapeutics, Inc. Revenues for the quarter ending 31 Mar 2024 was $1,235,000,000.
Source SEC data
View on sec.gov
Revenues, Quarterly (USD)

Hoth Therapeutics, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,235,000,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.